• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Hetlioz

FDA
Pharma

Vanda secures long-awaited FDA hearing in jet lag approval bid

The company has been pressing the FDA to hold a formal hearing on its proposed jet lag label expansion for Hetlioz since 2019.
Zoey Becker Mar 4, 2026 3:22pm
green light go go ahead advance yes streetlight

FDA signs off on Vanda's Bysanti for schizophrenia and bipolar I

Feb 23, 2026 11:35am
handshake

Vanda, FDA reach 'collaborative framework' after disputes

Oct 2, 2025 11:10am
Law Legal System Justice Crime concept Mallet Gavel Hammer and Scales on tabl

Vanda touts 'landmark' win over FDA in yearslong dispute

Aug 18, 2025 11:25am
Healthcare lawsuit image

Vanda sues FDA for right to promote off-label drug use

Apr 11, 2025 1:53pm
hostile takeover

Cycle's 2nd hostile takeover bid in 5 months rejected by Vanda

Oct 14, 2024 3:18pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings